[Gamma-hydroxybutyrate--an endogenous substance and an intoxicant]

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Gamma-hydroxybutyrate (GHB) is an endogenous compound in the mammalian brain.
• GHB exhibits properties consistent with neurotransmitter function.
• GHB has demonstrated utility in experimental epilepsy models and clinical applications such as anesthesia and treatment for sleep disorders and alcoholism.

Observation:

• GHB is increasingly being abused for its euphoric, sedative, and anabolic effects.
• Reported adverse effects of GHB abuse include coma and seizures.
• GHB abuse can precipitate a withdrawal syndrome characterized by insomnia, anxiety, and tremor.

Findings:

• The neuropharmacology of GHB is complex, involving interactions with specific receptors.
• GHB's therapeutic potential extends to various neurological and psychiatric conditions.
• Acute adverse effects, including seizures and a distinct withdrawal syndrome, are significant concerns associated with GHB abuse.

Implications:

• Understanding GHB's neuropharmacology is crucial for managing its therapeutic applications and mitigating abuse.
• Clinical vigilance is required to identify and manage GHB-induced toxicity and dependence.
• Further research into GHB's mechanisms of action may reveal novel therapeutic targets.